245 related articles for article (PubMed ID: 11831855)
21. Highly sensitive and selective fluorescence assays for rapid screening of endothelin-converting enzyme inhibitors.
Luciani N; de Rocquigny H; Turcaud S; Romieu A; Roques BP
Biochem J; 2001 Jun; 356(Pt 3):813-9. PubMed ID: 11389689
[TBL] [Abstract][Full Text] [Related]
22. Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1.
Takayanagi R; Liu W; Ito T; Ohnaka K; Nawata H
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S62-3. PubMed ID: 9595401
[TBL] [Abstract][Full Text] [Related]
23. Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides.
Mzhavia N; Pan H; Che FY; Fricker LD; Devi LA
J Biol Chem; 2003 Apr; 278(17):14704-11. PubMed ID: 12560336
[TBL] [Abstract][Full Text] [Related]
24. Endothelin-converting enzyme-1, abundance of isoforms a-d and identification of a novel alternatively spliced variant lacking a transmembrane domain.
Meidan R; Klipper E; Gilboa T; Muller L; Levy N
J Biol Chem; 2005 Dec; 280(49):40867-74. PubMed ID: 16186113
[TBL] [Abstract][Full Text] [Related]
25. Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations.
Schweizer A; Valdenaire O; Nelböck P; Deuschle U; Dumas Milne Edwards JB; Stumpf JG; Löffler BM
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):871-7. PubMed ID: 9396733
[TBL] [Abstract][Full Text] [Related]
26. The endothelin system and endothelin-converting enzyme in the brain: molecular and cellular studies.
Barnes K; Turner AJ
Neurochem Res; 1997 Aug; 22(8):1033-40. PubMed ID: 9239759
[TBL] [Abstract][Full Text] [Related]
27. Constitutive lysosomal targeting and degradation of bovine endothelin-converting enzyme-1a mediated by novel signals in its alternatively spliced cytoplasmic tail.
Emoto N; Nurhantari Y; Alimsardjono H; Xie J; Yamada T; Yanagisawa M; Matsuo M
J Biol Chem; 1999 Jan; 274(3):1509-18. PubMed ID: 9880527
[TBL] [Abstract][Full Text] [Related]
28. Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis.
Grantham JA; Schirger JA; Wennberg PW; Sandberg S; Heublein DM; Subkowski T; Burnett JC
Circulation; 2000 Apr; 101(16):1976-81. PubMed ID: 10779465
[TBL] [Abstract][Full Text] [Related]
29. Distribution of endothelin-converting enzyme-1 and neutral endopeptidase in human endometrium.
Iwase A; Ando H; Nagasaka T; Goto M; Harata T; Kikkawa F
J Histochem Cytochem; 2007 Dec; 55(12):1229-35. PubMed ID: 17712175
[TBL] [Abstract][Full Text] [Related]
30. On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer.
Smollich M; Götte M; Yip GW; Yong ES; Kersting C; Fischgräbe J; Radke I; Kiesel L; Wülfing P
Breast Cancer Res Treat; 2007 Dec; 106(3):361-9. PubMed ID: 17295044
[TBL] [Abstract][Full Text] [Related]
31. [Phe21]big endothelin-1(18-34) and [Ala31]big endothelin-1(18-34) inhibit the human endothelin-converting enzyme-1 (ECE-1) expressed in CHO-K1 cells in a different fashion.
Liu W; Takayanagi R; Ito T; Oba K; Nawata H
FEBS Lett; 1997 Dec; 420(1):103-6. PubMed ID: 9450558
[TBL] [Abstract][Full Text] [Related]
32. The neprilysin family in health and disease.
Turner AJ; Brown CD; Carson JA; Barnes K
Adv Exp Med Biol; 2000; 477():229-40. PubMed ID: 10849750
[TBL] [Abstract][Full Text] [Related]
33. Role of the hydrophobic transmembrane domain in membrane anchoring of endothelin-converting enzyme-1a.
Brooks SC; Ergul A
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S30-2. PubMed ID: 11078328
[TBL] [Abstract][Full Text] [Related]
34. Construction, expression and characterization of a soluble form of human endothelin-converting-enzyme-1.
Korth P; Egidy G; Parnot C; LeMoullec JM; Corvol P; Pinet F
FEBS Lett; 1997 Nov; 417(3):365-70. PubMed ID: 9409753
[TBL] [Abstract][Full Text] [Related]
35. Phosphorylation of endothelin converting enzyme-1 isoforms: relevance to subcellular localization.
Jafri F; Ergul A
Exp Biol Med (Maywood); 2006 Jun; 231(6):713-7. PubMed ID: 16740986
[TBL] [Abstract][Full Text] [Related]
36. The peptidase inhibitor CGS-26303 increases endothelin converting enzyme-1 expression in endothelial cells through accumulation of big endothelin-1.
Raoch V; Martinez-Miguel P; Arribas-Gomez I; Rodriguez-Puyol M; Rodriguez-Puyol D; Lopez-Ongil S
Br J Pharmacol; 2007 Oct; 152(3):313-22. PubMed ID: 17643133
[TBL] [Abstract][Full Text] [Related]
37. A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP).
Bur D; Dale GE; Oefner C
Protein Eng; 2001 May; 14(5):337-41. PubMed ID: 11438756
[TBL] [Abstract][Full Text] [Related]
38. Structure of human endothelin-converting enzyme I complexed with phosphoramidon.
Schulz H; Dale GE; Karimi-Nejad Y; Oefner C
J Mol Biol; 2009 Jan; 385(1):178-87. PubMed ID: 18992253
[TBL] [Abstract][Full Text] [Related]
39. Anti-peptide antibodies specific to rat endothelin-converting enzyme-1 isoforms reveal isoform localisation and expression.
Brown CD; Barnes K; Turner AJ
FEBS Lett; 1998 Mar; 424(3):183-7. PubMed ID: 9539147
[TBL] [Abstract][Full Text] [Related]
40. Characterization of PgPepO, a bacterial homologue of endothelin-converting enzyme-1.
Carson JA; Ansai T; Awano S; Yu W; Takehara T; Turner AJ
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():90S-93S. PubMed ID: 12193062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
